Insights, Clinical Trials, and Advancements in Pathology Automation

August 23, 2024

We are very excited to return to USCAP this year. We will be on the exhibit floor at Booth #208.

August 23, 2024

The main impact of automation that drives its development and adoption is consistency. Consistency is valuable in a Pathology lab because it delivers benefits across quality, timing, cost and reliability. However, the pursuit of consistency in the lab must be balanced with the inherent variety of specimens that the lab is tasked with analyzing. FormaPath is extremely mindful of figuring out which processes can be automated so that more time can be dedicated to more important and complex tasks.

August 23, 2024

By Michael Dugan M.D. For pathologists, realizing faster turnaround times and more reliable results with the help of AdiPress has the potential to improve cancer care by helping to deliver critical information on pathologic staging that will inform adjuvant care decisions for colon cancer patients.

August 23, 2024

FormaPath and Dr. John Tomaszewski, SUNY Distinguished Professor and Chair of Pathology and Anatomical Sciences at the Jacobs School of Medicine and Biomedical Sciences at UB, will use AdiPress to conduct comprehensive analyses of tissue specimens to identify and create lymph node-rich samples. This work will lead to the eventual creation of a digital lymph node database, which will allow FormaPath to explore computational methods—including AI—that identify and analyze lymph nodes with metastatic disease. 

August 23, 2024

FormaPath announced the commercial launch of AdiPress, the first and only automated tool to standardize lymph node dissection. With this innovation, cancer-focused pathology practices can now automate the recovery of lymph nodes within fatty cancer tissue, to ensure more precise staging of cancer patients to guide their follow up therapy intended to prevent cancer recurrence.